HIV Treatment
Clinical research activity is centred on HIV care, with interest in maintaining virological suppression in people living with HIV who are already stable on treatment.
- Antiretroviral therapy
- Virological control
- Maintenance treatment
The sponsor’s work reflects a focus on treatment strategies for long-term management of HIV infection in adult patients.
Two-drug antiretroviral regimens
Research interest includes simplified antiretroviral regimens designed to preserve treatment effectiveness while reducing regimen complexity in people living with HIV.
- DOR/3TC
- DTG/3TC
- Treatment simplification
This area involves comparison of dual therapy options for ongoing HIV maintenance care.
Long-term virological outcomes
The sponsor is engaged in research on sustained viral load control, with emphasis on preventing virological failure during continued treatment.
- Plasma viral load
- Suppressed HIV infection
- Durable response
Clinical interest extends to maintaining stable HIV RNA suppression over time in routine care settings.
Infectious disease care
As a hospital-based research sponsor in Paris, the organisation contributes to studies in tropical pathology and infectious diseases, with the current portfolio focused on HIV.
- Specialised HIV care
- Clinical follow-up
- Multisite collaboration
Its research activity is aligned with specialist management of chronic viral infection in a healthcare facility setting.
